UhiToh Japan

• INTEGRATING PERSONAL, HEREDITARY, AND POLYGENIC PROFILES VIA DEEP LEARNING-BASED RISK ESTIMATION FOR PRECLINICAL BREAST CANCER DIAGNOSIS
  3103-01
  SaturninoDomínguez Speaker Panama
• “THE TRIPLE TROUBLE” -VIRAL MARKER POSITIVITY, TUMOR AGGRESSIVENESS, AND OPPORTUNISTIC INFECTIONS IN BREAST CANCER
  3103-02
  BharathShivalingaiah Speaker India
• THE ASSOCIATION OF BODY MASS INDEX (BMI) AND HEIGHT WITH ONCOTYPE DX SCORES IN WOMEN WITH HORMONE RECEPTOR POSITIVE HER 2 NEGATIVE BREAST CANCER IN THE NYC METROPOLITAN AREA
  3103-03
  GeorgiaSyrnioti Speaker United States
• THE IMPACT OF METABOLIC SYNDROME ON THE DIAGNOSIS OF SECOND PRIMARY TUMORS IN WOMEN TREATED FOR BREAST CANCER: A RETROSPECTIVE COHORT ANALYSIS
  3103-04
  Ambrogio PLondero Speaker Italy
• INFLUENCE OF GERIATRIC ASSESSMENT ON TREATMENT DECISIONS IN ELDERLY BREAST CANCER PATIENTS
  3103-05
  Ambrogio PLondero Speaker Italy
• MINIMALLY INVASIVE RADIOFREQUENCY ABLATION (RFA) THERAPY IN PATIENTS WITH EARLY-STAGE BREAST CANCER
  3103-08
  UhiToh Speaker Japan
• CLINICAL CHARACTERISTICS OF HER2-LOW BREAST CANCER COMPARED TO HER2-NEGATIVE BREAST CANCER
  3103-09
  Cheng-HarYip Speaker Malaysia
• ENDOSCOPIC BREAST SURGERY FOR PERSONALIZATION OF BREAST CANCER TREATMENT
  3103-11
  KojiYamashita Speaker Japan
• RE-SENTINEL NODE BIOPSY IN PATIENTS WITH IPSILATERAL BREAST CANCER RECURRENCE AFTER BREAST CONSERVING SURGERY
  3103-12
  ZhiboShao Speaker China